Effect of nifedipine and cerivastatin on coronary endothelial function in patients with coronary artery disease -: The ENCORE I study (Evaluation of nifedipine and cerivastatin on recovery of coronary endothelial function)

被引:118
作者
Azancot, I
Balbi, M
Bonnier, JJRM
Desmet, W
Diederich, KW
Drexel, H
Dubois-Rande, J
Etbel, R
Ribeiro, VD
Glogar, H
Hanrath, P
Hess, OM
Heyer, G
Hugenholtz, PG
Lafont, A
Lüscher, TF
机构
[1] Core Lab Quantitat Coronary Angiog, Hannover, Germany
[2] Hannover Med Sch, D-3000 Hannover, Germany
[3] Univ Hosp, Freiburg, Germany
[4] InterCorNet, Fdn Cardiovasc Res, Zurich, Switzerland
[5] Bayer AG, D-5090 Leverkusen, Germany
关键词
coronary disease; endothelium; acetylcholine; angiography; drugs;
D O I
10.1161/01.CIR.0000046488.52939.BF
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background-Endothelial dysfunction is an important feature of atherosclerosis. Inhibition of the HMG-CoA pathway and of calcium channels improves endothelial function experimentally and in the forearm circulation. Thus, we investigated the effects of a statin and/or a calcium antagonist on coronary endothelial function in patients with coronary artery disease (CAD). Methods and Results-In 343 patients undergoing percutaneous coronary intervention in 29 centers, acetylcholine (10(-6) to 10(-4) mol/L) was infused in a coronary segment without angiographically significant CAD. Changes in coronary diameter were measured by quantitative angiography. Endothelium-independent responses were assessed by intracoronary adenosine (1.2 mg/mL) and nitroglycerin (250 mug). Thereafter, patients were randomized in a double-blind manner to placebo, cerivastatin 0.4 mg/d, nifedipine 30 to 60 mg/d, or their combination. Studies were repeated at 6 months. In the most constricted segment, nifedipine but not cerivastatin reduced vasoconstriction to acetylcholine (18.8% versus placebo 10.0%; P<0.05). Patients not taking ACE inhibitors showed a smaller improvement in the placebo group (6.0%), but nifedipine still had an effect (17.0%; P<0.05 versus placebo). Analysis of all evaluable coronary segments revealed an 11% reduction of acetylcholine-induced vasoconstriction in patients receiving nifedipine and cerivastatin (P<0.05 versus placebo). Cerivastatin lowered LDL cholesterol by 35% (P<0.001). Conclusions-The ENCORE I trial demonstrates that multicenter studies on coronary endothelial function are feasible. After 6 months' treatment, nifedipine improved coronary endothelial function in the most constricted segment. The combination of nifedipine and cerivastatin tended to improve endothelial function; however, this only reached significance in an analysis of all coronary segments.
引用
收藏
页码:422 / 428
页数:7
相关论文
共 41 条
[1]   Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) [J].
Cleeman, JI ;
Grundy, SM ;
Becker, D ;
Clark, LT ;
Cooper, RS ;
Denke, MA ;
Howard, WJ ;
Hunninghake, DB ;
Illingworth, DR ;
Luepker, RV ;
McBride, P ;
McKenney, JM ;
Pasternak, RC ;
Stone, NJ ;
Van Horn, L ;
Brewer, HB ;
Ernst, ND ;
Gordon, D ;
Levy, D ;
Rifkind, B ;
Rossouw, JE ;
Savage, P ;
Haffner, SM ;
Orloff, DG ;
Proschan, MA ;
Schwartz, JS ;
Sempos, CT ;
Shero, ST ;
Murray, EZ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19) :2486-2497
[2]  
Cosentino F, 1997, CIRCULATION, V96, P25
[3]   Clinical efficacy and safety of cerivastatin: Summary of pivotal phase IIb/III studies [J].
Davignon, J ;
Hanefeld, M ;
Nakaya, N ;
Hunninghake, DB ;
Insull, W ;
Ose, L .
AMERICAN JOURNAL OF CARDIOLOGY, 1998, 82 (4B) :32J-39J
[4]   Elevated C-reactive protein levels and impaired endothelial vasoreactivity in patients with coronary artery disease [J].
Fichtlscherer, S ;
Rosenberger, G ;
Walter, DH ;
Breuer, S ;
Dimmeler, S ;
Zeiher, AM .
CIRCULATION, 2000, 102 (09) :1000-1006
[5]   PRESERVATION OF ENDOTHELIUM-DEPENDENT VASCULAR RELAXATION IN CHOLESTEROL-FED RABBIT BY TREATMENT WITH THE CALCIUM BLOCKER PN-200110 [J].
HABIB, JB ;
BOSSALLER, C ;
WELLS, S ;
WILLIAMS, C ;
MORRISETT, JD ;
HENRY, PD .
CIRCULATION RESEARCH, 1986, 58 (02) :305-309
[6]   Predictive value of C-reactive protein and troponin T in patients with unstable angina: A comparative analysis [J].
Heeschen, C ;
Hamm, CW ;
Bruemmer, J ;
Simoons, ML .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2000, 35 (06) :1535-1542
[7]   IMPAIRED ENDOTHELIUM-DEPENDENT VASODILATION IN PATIENTS WITH INSULIN-DEPENDENT DIABETES-MELLITUS [J].
JOHNSTONE, MT ;
CREAGER, SJ ;
SCALES, KM ;
CUSCO, JA ;
LEE, BK ;
CREAGER, MA .
CIRCULATION, 1993, 88 (06) :2510-2516
[8]   REDUCING THE RISK OF CORONARY EVENTS - EVIDENCE FROM THE SCANDINAVIAN SIMVASTATIN SURVIVAL STUDY (4S) [J].
KJEKSHUS, J ;
PEDERSEN, TR .
AMERICAN JOURNAL OF CARDIOLOGY, 1995, 76 (09) :C64-C68
[9]   THE EFFECT OF CHOLESTEROL REDUCTION ON THE ENDOTHELIAL FUNCTION AND PROGRESSION OF ATHEROSCLEROSIS IN WHHL RABBITS [J].
KROON, AA ;
STALENHOEF, AFH ;
BUIKEMA, H ;
DEMACKER, PNM ;
DEWILDE, PCM ;
LEIJTEN, PA ;
VANGILST, WH .
ATHEROSCLEROSIS, 1993, 103 (02) :221-230
[10]  
Laufs U, 2000, CIRCULATION, V102, P3104